Literature DB >> 1764379

Verification of the cause of death in the trial of early detection of breast cancer. UK Trial of Early Detection of Breast Cancer Group. Trial Co-ordinating Centre.

J Chamberlain1, D Coleman, R Ellman, S Moss.   

Abstract

The limitations of case review as a means of identifying errors in death certificates among breast cancer patients in a non-randomised trial of screening are illustrated by the findings of this large study. Records of 928 out of 990 deaths were available for review but were very variable in quality. Definite errors were found in 1%, errors were suspected in a further 5% and uncertainty about the cause of death, despite review, was recorded for 27%. The overall bias in reporting breast cancer deaths was less than 1%. It was concluded that the certified underlying cause of death without review provides an adequate endpoint for evaluating breast cancer screening programmes in the UK.

Entities:  

Mesh:

Year:  1991        PMID: 1764379      PMCID: PMC1977852          DOI: 10.1038/bjc.1991.480

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  The clinical diagnoses of the causes of death and their reliability.

Authors:  E WAALER; M GRIMSTVEDT
Journal:  Acta Pathol Microbiol Scand       Date:  1958

2.  Edinburgh trial of screening for breast cancer: mortality at seven years.

Authors:  M M Roberts; F E Alexander; T J Anderson; U Chetty; P T Donnan; P Forrest; W Hepburn; A Huggins; A E Kirkpatrick; J Lamb
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

3.  Assessment of response and recurrence in breast cancer.

Authors:  J L Hayward; J W Meakin; H J Stewart
Journal:  Semin Oncol       Date:  1978-12       Impact factor: 4.929

4.  Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study.

Authors:  H J Collette; N E Day; J J Rombach; F de Waard
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

5.  On the signifcance of cause of death as recorded on death certificates in Hiroshima and Nagasaki, Japan.

Authors:  S Jablon; D M Angevine; Y S Matsumoto; M Ishida
Journal:  Natl Cancer Inst Monogr       Date:  1966-01

6.  The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.

Authors:  L Tabar; G Fagerberg; S W Duffy; N E Day
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

7.  A prospective study of 1152 hospital autopsies: I. Inaccuracies in death certification.

Authors:  H M Cameron; E McGoogan
Journal:  J Pathol       Date:  1981-04       Impact factor: 7.996

8.  Accuracy of death certification in an autopsied population with specific attention to malignant neoplasms and vascular diseases.

Authors:  L W Engel; J A Strauchen; L Chiazze; M Heid
Journal:  Am J Epidemiol       Date:  1980-01       Impact factor: 4.897

9.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

10.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

View more
  1 in total

1.  Errors in determination of net survival: cause-specific and relative survival settings.

Authors:  Chloe J Bright; Adam R Brentnall; Kate Wooldrage; Jonathon Myles; Peter Sasieni; Stephen W Duffy
Journal:  Br J Cancer       Date:  2020-02-10       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.